Hepatitis C Virus Infection in ESKD Patients

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1735-1737. doi: 10.2215/CJN.03700318. Epub 2018 Jul 31.

Authors

Marco Ladino^{1

2}, David Roth¹

Affiliations

¹ Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine; and.
² Nephrology and Hypertension Section, Miami Veterans Administration Hospital, Miami, Florida.

No abstract available

Keywords: ESKD; HCV; Hepacivirus; hepatitis; transplantation.

Publication types

Case Reports

MeSH terms

Aged
Antiviral Agents / therapeutic use*
Benzimidazoles / therapeutic use
Benzofurans / therapeutic use
Drug Combinations
Fluorenes / therapeutic use
Genotype
Hepacivirus / genetics
Hepatitis C, Chronic / complications*
Hepatitis C, Chronic / diagnosis
Hepatitis C, Chronic / drug therapy*
Humans
Imidazoles / therapeutic use
Kidney Failure, Chronic / complications*
Kidney Failure, Chronic / therapy
Kidney Transplantation
Male
Mass Screening
Quinoxalines / therapeutic use
Sofosbuvir
Uridine Monophosphate / analogs & derivatives
Uridine Monophosphate / therapeutic use

Substances

Antiviral Agents
Benzimidazoles
Benzofurans
Drug Combinations
Fluorenes
Imidazoles
Quinoxalines
elbasvir-grazoprevir drug combination
ledipasvir, sofosbuvir drug combination
Uridine Monophosphate
Sofosbuvir